[ORGANIZATION]
Pembrolizumab
Featured in 4 tracked stories · first seen
Situations
Clinical trial results in oncology and cardiovascular health
2 clusters · 4 sources · last updated
Latest: Clinical trials report mixed results for lung and bladder cancer treatments
Recent medical research and clinical trials have produced varied outcomes across oncology and cardiovascular studies. In oncology, research into breast cancer showed that combining cemiplimab and fianlimab with chemothe
Pembrolizumab combo approvals and trial data
4 clusters · 10 sources · last updated
Latest: Enfortumab Vedotin‑Pembrolizumab Combo Boosts Survival in Muscle‑Invasive Bladder Cancer
Since mid‑2026 the FDA and the EU have authorized pembrolizumab in combination with the HIF‑2α inhibitor belzutifan for adjuvant treatment of high‑risk clear‑cell renal cell carcinoma, and with the antibody‑drug conjugat
Also covered in
-
Moderna and Merck report successful Phase III melanoma vaccine trial
[HEALTH] · 7 sources ·
-
FDA approves sacituzumab govitecan as first‑line therapy for metastatic triple‑negative breast cancer
[HEALTH] · 2 sources ·